UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Funding sources of practice-changing trials

Annals of oncology, 2018-04, Vol.29 (4), p.1063-1065

2018

Volltextzugriff (PDF)

Ethinylestradiol is beneficial for postmenopausal patients with heavily pre-treated metastatic breast cancer after prior aromatase inhibitor treatment: a prospective study

British journal of cancer, 2013-09, Vol.109 (6), p.1537-1542

2013

Volltextzugriff (PDF)

Evaluation of an amplicon-based custom gene panel for the diagnosis of hereditary tumors

Neoplasma, 2020-01, Vol.67 (4), p.898-908

2020

Volltextzugriff (PDF)

“BRCAness”; a potential predictor needing the additional therapeutics

Breast (Edinburgh), 2017-03, Vol.32, p.S107-S108

2017

Volltextzugriff (PDF)

QS106. Sentinel Lymph Node Biopsy Using SPECT-CT Fusion Imaging in Patients With Breast Cancer and Its Clinical Usefulness

The Journal of surgical research, 2009, Vol.151 (2), p.287-287

2009

Volltextzugriff (PDF)

Abstract P1-02-09: Clinical significance of sequential measurements of ESR1 mutations in plasma cell-free DNA in estrogen receptor positive recurrent metastatic breast cancer patients

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P1-P1-02-09

2017

Volltextzugriff (PDF)

Abstract P1-02-13: Differential expression of exosomal miRNAs between breast cancer patients with recurrence and no-recurrence

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P1-P1-02-13

2017

Volltextzugriff (PDF)

Abstract P6-09-48: Development of a predictive model by gene expression profiles for pathological CR after neoadjuvant chemotherapy in ER-positive/HER2-negative breast cancer

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P6-P6-09-48

2017

Volltextzugriff (PDF)

Abstract P6-09-46: A comprehensive analysis of GNAS DNA copy number, levels of mRNA and protein expression in primary breast cancer

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P6-P6-09-46

2017

Volltextzugriff (PDF)

Abstract P6-07-07: Clinical significance of ESR1 mutations using droplet digital polymerase chain reaction assay in 325 breast cancer samples

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P6-P6-07-07

2016

Volltextzugriff (PDF)

Abstract P3-07-11: High activation of PI3K pathway defined by PIK3CA mutation, PTEN, and INPP4B expression are associated with trastuzumab efficacy in HER2-positive breast cancer

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P3-P3-07-11

2016

Volltextzugriff (PDF)

Targeting interleukin-6 receptor inhibits human oral squamous cell carcinoma-related angiogenesis

International journal of oral and maxillofacial surgery, 2009, Vol.38 (5), p.538-539

2009

Volltextzugriff (PDF)

Abstract P6-05-06: Serum estradiol levels in postmenopausal ER+/PR- breast cancer are lower than those in postmenopausal ER+/PR

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P6-P6-05-06

2012

Volltextzugriff (PDF)

Abstract P4-09-01: FGFR1 protein expression is associated with prognosis in primary breast cancer: A comprehensive analysis of gene copy number, mRNA and protein expression

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P4-P4-09-01

2016

Volltextzugriff (PDF)

Abstract P1-14-04: Subsequent endocrine therapy after becoming to resistance of ‘estrogen therapy’ is beneficial as a salvage treatment for the late stage metastatic breast cancer

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P1-P1-14-04

2013

Volltextzugriff (PDF)

P256 - “BRCAness”; a potential predictor needing the additional therapeutics

Breast (Edinburgh), 2017-03, Vol.32, p.S107-S108

2017

Volltextzugriff (PDF)

P5-03-02: Aurora A Is Closely Linked to an Aggressive Phenotype of Breast Cancer

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P5-P5-03-02

2011

Volltextzugriff (PDF)

Abstract P2-14-03: “Ethinylestradiol” is beneficial for postmenopausal advanced breast cancer patients heavily pre-treated with endocrine agents

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P2-P2-14-03

2012

Volltextzugriff (PDF)

Does Local Anesthetic Patch Reduce the Injection Site Pain of Fulvestrant in Postmenopausal Breast Cancer?

Annals of oncology, 2013-11, Vol.24, p.ix90

2013

Volltextzugriff (PDF)

The High DSS1 Expression Involved in BRCA2 Stability is a Marker for Breast Cancer of Poor Prognosis

Annals of oncology, 2014-05, Vol.25, p.i18-i18

2014

Volltextzugriff (PDF)

43PTHE HIGH DSS1 EXPRESSION INVOLVED IN BRCA2 STABILITY IS A MARKER FOR BREAST CANCER OF POOR PROGNOSIS

Annals of oncology, 2014-05, Vol.25 (suppl_1), p.i14-i14

2014

Volltextzugriff (PDF)

Abstract P6-09-06: BRCAness as a prognostic marker in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: A multicenter retrospective study

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P6-P6-09-06

2019

Volltextzugriff (PDF)

Abstract P1-14-01: Randomized controlled trial of toremifene 120 mg compared with exemestane 25 mg after prior non-steroidal aromatase inhibitor treatment in postmenopausal women with hormone receptor-positive metastatic breast cancer (Hi-FAIR ex study)

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P1-P1-14-01

2013

Volltextzugriff (PDF)

Clinical significance of anti-p53 antibody in the sera in patients with breast cancer

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e11508-e11508

2011

Volltextzugriff (PDF)

Midkine in the plasma as a novel breast cancer marker

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.1142-1142

2010

Volltextzugriff (PDF)

1 – 25 von 90

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(76)

Publikationsform

Sprache

Englisch
(81)
Japanisch
(32)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Funding sources of practice-changing trials

Ethinylestradiol is beneficial for postmenopausal patients with heavily pre-treated metastatic breast cancer after prior aromatase inhibitor treatment: a prospective study

Evaluation of an amplicon-based custom gene panel for the diagnosis of hereditary tumors

“BRCAness”; a potential predictor needing the additional therapeutics

QS106. Sentinel Lymph Node Biopsy Using SPECT-CT Fusion Imaging in Patients With Breast Cancer and Its Clinical Usefulness

Abstract P1-02-09: Clinical significance of sequential measurements of ESR1 mutations in plasma cell-free DNA in estrogen receptor positive recurrent metastatic breast cancer patients

Abstract P1-02-13: Differential expression of exosomal miRNAs between breast cancer patients with recurrence and no-recurrence

Abstract P6-09-48: Development of a predictive model by gene expression profiles for pathological CR after neoadjuvant chemotherapy in ER-positive/HER2-negative breast cancer

Abstract P6-09-46: A comprehensive analysis of GNAS DNA copy number, levels of mRNA and protein expression in primary breast cancer

Abstract P6-07-07: Clinical significance of ESR1 mutations using droplet digital polymerase chain reaction assay in 325 breast cancer samples

Abstract P3-07-11: High activation of PI3K pathway defined by PIK3CA mutation, PTEN, and INPP4B expression are associated with trastuzumab efficacy in HER2-positive breast cancer

Targeting interleukin-6 receptor inhibits human oral squamous cell carcinoma-related angiogenesis

Abstract P6-05-06: Serum estradiol levels in postmenopausal ER+/PR- breast cancer are lower than those in postmenopausal ER+/PR

Abstract P4-09-01: FGFR1 protein expression is associated with prognosis in primary breast cancer: A comprehensive analysis of gene copy number, mRNA and protein expression

Abstract P1-14-04: Subsequent endocrine therapy after becoming to resistance of ‘estrogen therapy’ is beneficial as a salvage treatment for the late stage metastatic breast cancer

P256 - “BRCAness”; a potential predictor needing the additional therapeutics

P5-03-02: Aurora A Is Closely Linked to an Aggressive Phenotype of Breast Cancer

Abstract P2-14-03: “Ethinylestradiol” is beneficial for postmenopausal advanced breast cancer patients heavily pre-treated with endocrine agents

Does Local Anesthetic Patch Reduce the Injection Site Pain of Fulvestrant in Postmenopausal Breast Cancer?

The High DSS1 Expression Involved in BRCA2 Stability is a Marker for Breast Cancer of Poor Prognosis

43PTHE HIGH DSS1 EXPRESSION INVOLVED IN BRCA2 STABILITY IS A MARKER FOR BREAST CANCER OF POOR PROGNOSIS

Abstract P6-09-06: BRCAness as a prognostic marker in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: A multicenter retrospective study

Abstract P1-14-01: Randomized controlled trial of toremifene 120 mg compared with exemestane 25 mg after prior non-steroidal aromatase inhibitor treatment in postmenopausal women with hormone receptor-positive metastatic breast cancer (Hi-FAIR ex study)

Clinical significance of anti-p53 antibody in the sera in patients with breast cancer

Midkine in the plasma as a novel breast cancer marker

Suchergebnisse filtern